Thrivent Financial for Lutherans »

Apellis Pharmaceuticals shares owned by Thrivent Financial for Lutherans

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Thrivent Financial for Lutherans from 13F filings

Historical chart of Thrivent Financial for Lutherans investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Thrivent Financial for Lutherans

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 68k 40.23
2023-09-30 $3.0M 80k 38.04

More positions owned by Thrivent Financial for Lutherans

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
Caterpillar (CAT)

View all positions for Thrivent Financial for Lutherans

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals